Inflammatory networks underlying colorectal cancer

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Nature Immunology

• Publication date

  2016-02-16

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/ni.3384PMID 26882261
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer

  2016cited by this paper
• Genetics and Pathogenesis of Inflammatory Bowel Disease.

  2016cited by this paper
• Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome.

  2015cited by this paper
• AIMing 2 Curtail Cancer.

  2015cited by this paper
• Impacts of Gut Bacteria on Human Health and Diseases

  2015cited by this paper
• Mechanisms of inflammasome activation: recent advances and novel insights.

  2015cited by this paper
• Corrigendum: A diverse range of gene products are effectors of the type I interferon antiviral response

  2015cited by this paper
• Microbiota-Modulated Metabolites Shape the Intestinal Microenvironment by Regulating NLRP6 Inflammasome Signaling.

  2015cited by this paper
• Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis.

  2015cited by this paper
• Gut microbiota facilitates dietary heme-induced epithelial hyperproliferation by opening the mucus barrier in colon

  2015cited by this paper
• Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity

  2015cited by this paper
• Epithelial-derived IL-18 regulates Th17 cell differentiation and Foxp3+ Treg cell function in the intestine

  2015cited by this paper
• Inflammasomes of the intestinal epithelium.

  2015cited by this paper
• Critical Role for the DNA Sensor AIM2 in Stem Cell Proliferation and Cancer.

  2015cited by this paper
• Autophagy in cellular metabolism and cancer.

  2015cited by this paper
• PD-1 blockade in tumors with mismatch repair deficiency.

  2015cited by this paper
• Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma

  2015cited by this paper
• Emerging cytokine networks in colorectal cancer

  2015cited by this paper
• Intestinal inhibition of Atg7 prevents tumour initiation through a microbiome-influenced immune response and suppresses tumour growth

  2015cited by this paper
• PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.

  2015cited by this paper
• Intestinal barrier dysfunction in cirrhosis: Current concepts in pathophysiology and clinical implications.

  2015cited by this paper
• Role of autophagy in the maintenance and function of cancer stem cells.

  2015cited by this paper
• Nucleic Acid–Sensing Receptors: Rheostats of Autoimmunity and Autoinflammation

  2015cited by this paper
• FDA Approval: Siltuximab for the Treatment of Patients with Multicentric Castleman Disease

  2015cited by this paper
• The intestinal epithelium as guardian of gut barrier integrity

  2015cited by this paper
• Aspirin and COX-2 inhibitor use in patients with stage III colon cancer.

  2015cited by this paper
• Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack.

  2015cited by this paper
• DNA damage primes the type I interferon system via the cytosolic DNA sensor STING to promote anti-microbial innate immunity.

  2015cited by this paper
• Microbes, microbiota, and colon cancer.

  2014cited by this paper
• Neutrophil infiltration favors colitis-associated tumorigenesis by activating the interleukin-1 (IL-1)/IL-6 axis

  2014cited by this paper
• NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion.

  2014cited by this paper
• Critical role for IL-1β in DNA damage-induced mucositis

  2014cited by this paper
• Ectopic lymphoid-like structures in infection, cancer and autoimmunity

  2014cited by this paper
• Hepatic RIG-I predicts survival and interferon-α therapeutic response in hepatocellular carcinoma.

  2014cited by this paper
• Tertiary lymphoid structures in cancer and beyond.

  2014cited by this paper
• Cutting Edge: STING Mediates Protection against Colorectal Tumorigenesis by Governing the Magnitude of Intestinal Inflammation

  2014cited by this paper
• Interleukin-17 receptor a signaling in transformed enterocytes promotes early colorectal tumorigenesis.

  2014cited by this paper
• Case–Control Study of Aspirin Use and Risk of Pancreatic Cancer

  2014cited by this paper
• A Phase I/II, Multiple-Dose, Dose-Escalation Study of Siltuximab, an Anti-Interleukin-6 Monoclonal Antibody, in Patients with Advanced Solid Tumors

  2014cited by this paper
• Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study

  2014cited by this paper
• Lack of Absent in Melanoma 2 (AIM2) expression in tumor cells is closely associated with poor survival in colorectal cancer patients

  2014cited by this paper
• IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis.

  2014cited by this paper
• Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms

  2013cited by this paper
• Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties.

  2013cited by this paper
• Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancer.

  2013cited by this paper
• Mutant p53 prolongs NF-κB activation and promotes chronic inflammation and inflammation-associated colorectal cancer.

  2013cited by this paper
• Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and can be targeted therapeutically.

  2013cited by this paper
• Endemic Fungal Infections in Inflammatory Bowel Disease Associated with Anti-TNF Antibody Therapy

  2013cited by this paper
• DNA damage sensor MRE11 recognizes cytosolic double-stranded DNA and induces type I interferon by regulating STING trafficking

  2013cited by this paper
• The DNA damage sensor MRE11 recognizes cytosolic double-stranded DNA and induces type I interferon by regulating STING trafficking

  2013cited by this paper
• Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours

  2013cited by this paper
• Paneth cells as a site of origin for intestinal inflammation

  2013cited by this paper
• Loss of p53 in enterocytes generates an inflammatory microenvironment enabling invasion and lymph node metastasis of carcinogen-induced colorectal tumors.

  2013cited by this paper
• Clinical use of anti-TNF therapy and increased risk of infections

  2013cited by this paper
• The origins of tumor-promoting inflammation.

  2013cited by this paper
• A senescence-inflammatory switch from cancer-inhibitory to cancer-promoting mechanism.

  2013cited by this paper
• Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model

  2013cited by this paper
• Trends in overall and cause-specific mortality among patients with inflammatory bowel disease from 1982 to 2010.

  2013cited by this paper
• Materials for : Host-microbe interactions shape genetic risk for inflammatory bowel disease

  2012cited by this paper
• A bacterial driver–passenger model for colorectal cancer: beyond the usual suspects

  2012cited by this paper
• Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth

  2012cited by this paper
• IL-6 receptor inhibition positively modulates bone balance in rheumatoid arthritis patients with an inadequate response to anti-tumor necrosis factor therapy: biochemical marker analysis of bone metabolism in the tocilizumab RADIATE study (NCT00106522).

  2012cited by this paper
• The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: longitudinal results from the British Society for Rheumatology Biologics Register

  2012cited by this paper
• Incidence of serious respiratory infections in patients with rheumatoid arthritis treated with tocilizumab

  2012cited by this paper
• Cancer-related inflammation: common themes and therapeutic opportunities.

  2012cited by this paper
• Chronic epithelial NF-κB activation accelerates APC loss and intestinal tumor initiation through iNOS up-regulation

  2012cited by this paper
• DNA excision repair

  2012cited by this paper
• Calpain activation by the Shigella flexneri effector VirA regulates key steps in the formation and life of the bacterium's epithelial niche.

  2012cited by this paper
• NF-κB inhibition delays DNA damage-induced senescence and aging in mice.

  2012cited by this paper
• Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival.

  2012cited by this paper
• Inflammasomes in health and disease

  2012cited by this paper
• DNA-PK is a DNA sensor for IRF-3-dependent innate immunity

  2012cited by this paper
• Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis

  2011cited by this paper
• TLR9 and the NLRP3 inflammasome link acinar cell death with inflammation in acute pancreatitis.

  2011cited by this paper
• The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases

  2011cited by this paper
• Importance of disrupted intestinal barrier in inflammatory bowel diseases

  2011cited by this paper
• COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirin

  2011cited by this paper
• Inflammation meets cancer, with NF-κB as the matchmaker

  2011cited by this paper
• CKIα ablation highlights a critical role for p53 in invasiveness control

  2011cited by this paper
• A diverse array of gene products are effectors of the type I interferon antiviral response

  2011cited by this paper
• Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts

  2011cited by this paper
• Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Genetics and pathogenesis of inflammatory bowel disease

  2011cited by this paper
• Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer.

  2011cited by this paper
• A Randomized Placebo-Controlled Prevention Trial of Aspirin and/or Resistant Starch in Young People with Familial Adenomatous Polyposis

  2011cited by this paper
• NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis.

  2011cited by this paper
• Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling.

  2011cited by this paper
• Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

  2011cited by this paper
• Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials.

  2011cited by this paper
• Long-term use of aspirin and the risk of gastrointestinal bleeding.

  2011cited by this paper
• Innate immune mechanisms of colitis and colitis-associated colorectal cancer

  2011cited by this paper
• Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury

  2011cited by this paper
• Prostaglandin E2 modulates components of the Wnt signaling system in bone and prostate cancer cells.

  2010cited by this paper
• Induction and rescue of Nod2-dependent Th1-driven granulomatous inflammation of the ileum

  2010cited by this paper
• Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy

  2010cited by this paper
• The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis.

  2010cited by this paper
• Pattern recognition receptors and inflammation.

  2010cited by this paper
• Molecular detection, quantification, and isolation of Streptococcus gallolyticus bacteria colonizing colorectal tumors: inflammation-driven potential of carcinogenesis via IL-1, COX-2, and IL-8

  2010cited by this paper
• Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4

  2010cited by this paper

• Proteomics-Guided Discovery and Computational Validation of Stable, Cell-Penetrating Plasma Peptides for Targeted Drug Delivery in Colorectal Cancer

  2026cites this paper
• Nanomedicines: An Update of Diagnostic and Therapeutic Applications in Multiple Cancers.

  2026cites this paper
• Targeting Microbiome Metabolites: Reshaping Immunotherapy and Clinical Management Strategies for Colorectal Cancer

  2026cites this paper
• Colonic Aging and Colorectal Cancer: An Unignorable Interplay and Its Translational Implications

  2025cites this paper
• The role of adipogenic niche resident cells in colorectal cancer progression in relation to obesity

  2025cites this paper
• The impact of apelin on polarization of macrophages in the microenvironment of colon cancer

  2025cites this paper
• Autoimmune diseases and risk of gastrointestinal cancer: an umbrella review of meta-analyses of observational studies.

  2025cites this paper
• Modulation of Intestinal Barrier Function and Wnt/β-Catenin Pathway by Sanzi Formula in Colorectal Adenoma Development

  2025cites this paper
• The inflammation-aging axis: Shared and distinct mechanisms in physiological gut aging and IBD-associated accelerated gut aging.

  2025cites this paper
• Moxibustion regulates KDM4D expression and modulates lipid metabolism to inhibit tumor proliferation in CAC mice

  2025cites this paper
• Spatially defined multicellular functional units in colorectal cancer revealed from single cell and spatial transcriptomics

  2025cites this paper
• Morphofunctional changes in the immune system in colitis-associated colorectal cancer in tolerant and susceptible to hypoxia mice

  2025cites this paper
• Itaconate and obesity-related hormones promote tumor progression – new insights on metabolic dysfunction in early-onset colon cancer

  2025cites this paper
• Structural elucidation of an Astragalus acidic polysaccharide and its anti-colon cancer activity through modulation of JNK/MAPK and NLRP3/IL-1β signaling pathways

  2025cites this paper
• Linear inverse association between prognostic nutritional index and colorectal cancer risk based on NHANES data

  2025cites this paper
• Clinical Detection and Management of Colorectal Cancer Concerning the Gut Microbiome

  2025cites this paper
• Chlorogenic acid and intestinal health: mechanistic insights and therapeutic applications.

  2025cites this paper
• Immunological changes and recovery-related factors in older patients with colon cancer: A pilot trial.

  2025cites this paper
• The role of intestinal macrophage polarization in colitis-associated colon cancer

  2025cites this paper
• An inulin-type fructan CP-A from Codonopsis pilosula combined with 5-Fluorouracil alleviates colitis-associated tumorigenesis via inhibition of EGFR/AKT/ERK signaling pathway and regulation of intestinal flora.

  2025cites this paper
• Jacalin Attenuates Colitis-Associated Colorectal Carcinogenesis by Inhibiting Tumor Cell Proliferation and Intestinal Inflammation.

  2025cites this paper
• Temporal and Spatial Metabolic Shifts Revealing the Transition from Ulcerative Colitis to Colitis‐Associated Colorectal Cancer

  2025cites this paper
• Protective Effect of Ganjang, a Traditional Fermented Soy Sauce, on Colitis-Associated Colorectal Cancer in Mice

  2025cites this paper
• Lypd6b depletion promotes CD8+ T cell-mediated anti-tumor immunity via metabolic reprogramming in colorectal cancer

  2025cites this paper
• CCR9 shapes the immune microenvironment of colorectal cancer modulating the balance between intratumoral CD8+ T cell and FoxP3+ Helios+ Treg subpopulations

  2025cites this paper
• Gut colonization of Bacteroides plebeius suppresses colitis-associated colon cancer development

  2025cites this paper
• Assessment of FOXO4 Gene Expression and Serum Keap-1, Aldolase, IL-18, and IL-22 Levels in Patients with Colorectal Cancer

  2025cites this paper
• Neutrophil Spatiotemporal Regulatory Networks: Dual Roles in Tumor Growth Regulation and Metastasis

  2025cites this paper
• Comprehensive analysis based on the ubiquitination- and deubiquitylation-related genes reveals the function of NEURL3 in esophageal squamous cell carcinoma

  2025cites this paper
• LARS2 DNA methylation predicts the prognosis in colon cancer

  2025cites this paper
• Fermented guava (Psidium guajava) by Lactiplantibacillus plantarum NCU0011129 attenuates azoxymethane/dextran sodium sulfate-induced colorectal cancer in mice: Restructuring gut microbiota and enhancing intestinal barrier function

  2025cites this paper
• Prognostic value and clinicopathological significance of pre-and post-treatment systemic immune-inflammation index in colorectal cancer patients: a meta-analysis

  2025cites this paper
• Spatially defined multicellular functional units in colorectal cancer revealed from single cell and spatial transcriptomics

  2025cites this paper
• The Impact of the Microbiota on the Immune Response Modulation in Colorectal Cancer

  2025cites this paper
• New sights of immunometabolism and agent progress in colitis associated colorectal cancer

  2024cites this paper
• Annona muricata Leaves Extract Inhibit Carcinogenesis and Regulates Inflammatory Responses in AOM/DSS-Induced Colitis-Associated Carcinogenesis Mice

  2024cites this paper
• Exploring the importance of kynurenine pathway (KP) approaches in colorectal cancer (CRC)

  2024cites this paper
• 27-Hydroxycholesterol activates the GSK-3β/β-catenin signaling pathway resulting in intestinal fibrosis by inducing oxidative stress: effect of dietary interventions

  2024cites this paper
• Gamabufotalin inhibits colitis-associated colorectal cancer by suppressing transcription factor STAT3.

  2024cites this paper
• Microbial Metabolites-Induced Epigenetic Modifications for Inhibition of Colorectal Cancer: Current Status and Future Perspectives.

  2024cites this paper
• The gut–immune axis during hypertension and cardiovascular diseases

  2024cites this paper
• NAMPT‐Driven M2 Polarization of Tumor‐Associated Macrophages Leads to an Immunosuppressive Microenvironment in Colorectal Cancer

  2024cites this paper
• Specific microbiome patterns and their association with breast cancer: the intestinal microbiota as a potential biomarker and therapeutic strategy

  2024cites this paper
• Colorectal cancer and gut microbiota

  2024cites this paper
• Prognostic significance of systemic immune inflammation index in patients with urothelial carcinoma: a systematic review and meta-analysis

  2024cites this paper
• Microbiota-associated mechanisms in colorectal cancer.

  2024cites this paper
• SIX4 Activation in Inflammatory Response Drives the Transformation of Colorectal Epithelium into Inflammation and Tumor via Feedback-Enhancing Inflammatory Signaling to Induce Tumor Stemness Signaling

  2024cites this paper
• Retinoblastoma-binding Protein 9 Suppresses Intestinal Inflammation and Inflammation-induced Tumorigenesis in Mice

  2024cites this paper
• Serum bilirubin levels and risk of colorectal cancer in Korean adults: results from the Korean Genome and Epidemiology Study-Health Examinee (KoGES-HEXA) Cohort Study

  2024cites this paper
• Current advance of nanotechnology in diagnosis and treatment for malignant tumors

  2024cites this paper
• Double-layer probiotic encapsulation for enhanced bacteriotherapy against inflammatory bowel disease

  2024cites this paper
• Integration of microbiome, metabolomics and transcriptome for in-depth understanding of berberine attenuates AOM/DSS-induced colitis-associated colorectal cancer.

  2024cites this paper
• Circadian rhythm regulates the function of immune cells and participates in the development of tumors

  2024cites this paper
• Inflammation and Colorectal Cancer: A Meta-Analysis of the Prognostic Significance of the Systemic Immune–Inflammation Index (SII) and the Systemic Inflammation Response Index (SIRI)

  2024cites this paper
• Combination of bazedoxifene with chemotherapy and SMAC-mimetics for the treatment of colorectal cancer

  2024cites this paper
• Plasma 25-hydroxyvitamin D deficiency in the peri-operative period is associated with survival outcome in colorectal cancer patients: a meta-analysis

  2024cites this paper
• IL-1β mediates Candida tropicalis-induced immunosuppressive function of MDSCs to foster colorectal cancer

  2024cites this paper
• Therapeutic potential of traditional Chinese medicine in the prevention and treatment of digestive inflammatory cancer transformation: Portulaca oleracea L. as a promising drug.

  2024cites this paper
• Gut Microbiome–Colorectal Cancer Relationship

  2024cites this paper
• The State-of-the-Art Mechanisms and Antitumor Effects of Somatostatin in Colorectal Cancer: A Review

  2024cites this paper
• Heme oxygenase‐1 alleviates allergic airway inflammation by suppressing NF‐κB‐mediated pyroptosis of bronchial epithelial cells

  2024cites this paper
• Targeting the "tumor microenvironment": RNA-binding proteins in the spotlight in colorectal cancer therapy.

  2024cites this paper
• Construction and validation of a chromatin regulator-related gene signature for prognostic and therapeutic significance of clear cell renal cell carcinoma

  2024cites this paper
• Application of Nanomedicine in Tumor Targeting Inflammatory Pathway.

  2024cites this paper
• Small Bowel Cancer in Crohn’s Disease

  2024cites this paper
• Distinct roles for interleukin-23 receptor signaling in regulatory T cells in sporadic and inflammation-associated carcinogenesis

  2024cites this paper
• WAY-262611 ameliorates the inflammatory bowel disease by activating Wnt/β-catenin pathway

  2024cites this paper
• Anchang Yuyang Decoction inhibits experimental colitis-related carcinogenesis by regulating PPAR signaling pathway and affecting metabolic homeostasis of host and microbiota.

  2024cites this paper
• Mechanic evaluation of Wu-Mei-Pill on colitis-associated colorectal cancer: An integrated transcriptomics, metabolomics, and experimental validation study.

  2024cites this paper
• Three‐in‐One Peptide Prodrug with Targeting, Assembly and Release Properties for Overcoming Bacterium‐Induced Drug Resistance and Potentiating Anti‐Cancer Immune Response

  2024cites this paper
• Association between lactate dehydrogenase to albumin ratio and acute kidney injury in patients with sepsis: a retrospective cohort study

  2024cites this paper
• Progressive Changes of Colitis Into Colorectal Cancer Associated With Changes in Neutrophil Lymphocyte Ratio, Serum, Micrornas and Infiltrate Neutrophils

  2024cites this paper
• ORF virus causes tumor-promoting inflammation in sheep and goats

  2024cites this paper
• Interaction between Gut Microbiota and Dendritic Cells in Colorectal Cancer

  2023cites this paper
• ZNF70 regulates IL-1β secretion of macrophages to promote the proliferation of HCT116 cells via activation of NLRP3 inflammasome and STAT3 pathway in colitis-associated colorectal cancer.

  2023cites this paper
• MZB1-mediated IgA secretion suppresses the development and progression of colorectal cancer triggered by gut inflammation.

  2023cites this paper
• An Insight on Gut Flora, Colorectal Cancer Mechanism, and Treatment Strategies

  2023cites this paper
• HER-2 Expression in Colorectal Cancer and Its Correlation with Immune Cell Infiltration

  2023cites this paper
• Genetic Variants as Predictors of the Success of Colorectal Cancer Treatments

  2023cites this paper
• Yogurt Prevents Colitis-Associated Colorectal Cancer in Mice.

  2023cites this paper
• A new strategy for treating colorectal cancer: Regulating the influence of intestinal flora and oncolytic virus on interferon

  2023cites this paper
• MiR-597-5p inhibits carcinogenesis and macrophage recruitment in colitis-related colorectal cancer via reducing the expression of CXCL5

  2023cites this paper
• Autophagy in colitis-associated colon cancer: exploring its potential role in reducing initiation and preventing IBD-Related CAC development

  2023cites this paper
• Dynamic interplay of intratumoral microbiota within the colorectal cancer microenvironment

  2023cites this paper
• Methyl cinnamate protects against dextran sulfate sodium-induced colitis in mice by inhibiting the MAPK signaling pathway

  2023cites this paper
• Glutathione-depleted cyclodextrin pseudo-polyrotaxane nanoparticles for anti-inflammatory oxaliplatin (IV) prodrug delivery and enhanced colorectal cancer therapy

  2023cites this paper
• Role of gut microbiota and bacterial metabolites in mucins of colorectal cancer

  2023cites this paper
• Transforming Growth Factor Beta Promotes Inflammation and Tumorigenesis in Smad4‐Deficient Intestinal Epithelium in a YAP‐Dependent Manner

  2023cites this paper
• NAD+ Metabolism and Immune Regulation: New Approaches to Inflammatory Bowel Disease Therapies

  2023cites this paper
• Gut microbiota in colorectal cancer development and therapy

  2023cites this paper
• From Omic Layers to Personalized Medicine in Colorectal Cancer: The Road Ahead

  2023cites this paper
• A novel inflammation-related signature for predicting prognosis and characterizing the tumor microenvironment in colorectal cancer

  2023cites this paper
• Transcriptomics and experimental validation-based approach to understand the effect and mechanism of Huangqin tang interfeience with colitis associated colorectal cancer

  2023cites this paper
• Spotlight on NLRP6 and Tumor Research Situation: A Potential Cancer Participant

  2023cites this paper
• Indole metabolites and colorectal cancer: Gut microbial tryptophan metabolism, host gut microbiome biomarkers, and potential intervention mechanisms.

  2023cites this paper
• Emerging glyco-risk prediction model to forecast response to immune checkpoint inhibitors in colorectal cancer

  2023cites this paper
• IL8 derived from macrophages inhibits CD8+ T-cell function by downregulating TIM3 expression through IL8-CXCR2 axis in patients with advanced colorectal cancer.

  2023cites this paper
• Protein stabilization of ITF2 by NF-κB prevents colitis-associated cancer development

  2023cites this paper
• Prevention of Colitis-Associated Cancer via Oral Administration of M13-Loaded Lipid Nanoparticles

  2023cites this paper
• Effects of Cheonggukjang (Fermented Soybean) on the Development of Colitis-Associated Colorectal Cancer in Mice

  2023cites this paper